-
AI ignites 'ignored sector' for Japan chipmaker Kioxia
-
Seoul leads Asian stocks higher as US inflation eases rate fears
-
Writers union sues to block US Paramount deal
-
Duped or spun with juju: how sex trade trafficks Nigerian women
-
UK announces social media curfew for older teens
-
France fireworks fizzle as Spain advance to World Cup final
-
Italy court to rule in deadly bridge collapse case
-
Gibraltar and Spain end border checks
-
Tuchel unfazed by history ahead of England v Argentina World Cup semi
-
UK climate now hotter, sunnier: weather agency
-
Scaloni says fatigue not a concern for Argentina in World Cup semi-final
-
Rice declared fit to start for England in World Cup semi-final
-
Mac Allister calls on Argentina to channel Maradona spirit in England World Cup clash
-
'Immense disappointment': Mbappe rues end of World Cup dream
-
Key battles as England face Argentina in World Cup semi-final
-
Viva! Delirium in Madrid as Spain reach World Cup final
-
Deschamps says France 'devastated' by defeat, questions referee
-
NFL Texans co-founder McNair dead at 89
-
IBM shares plunge 25% as AI spending boom disrupts business
-
Spain deliver World Cup masterclass against France to reach final
-
Majestic Spain stun France to reach World Cup final
-
Brook upbeat about England ODI form amid Test captaincy uncertainty
-
Nasdaq rebounds as cooling US inflation weighs on dollar
-
Record-smashing heat wave surges from West to eastern US, Canada
-
Hurdles record holder Tharp claims first win as professional in Budapest
-
Wildfires that ravaged historic forest outside Paris contained
-
McIlroy and Scheffler unconcerned by their place in golf history
-
NY state pauses new large data center projects in US first
-
Gill enjoys more Edgbaston success as India beat England in 1st ODI
-
England v Argentina: World Cup battles
-
IBM shares plunge as AI spending boom disrupts business
-
Argentina v England in the World Cup: much more than just a game
-
NY pauses new large data center projects for one year
-
Green groups sue to block Trump rule gutting species habitat protections
-
First day of new Lebanon-Israel talks in Rome has ended: US official
-
Man Utd sign Aston Villa midfielder Tielemans
-
Cuba faces third nationwide blackout in less than 10 days
-
Pogacar inspired by Djokovic after Tour de France jeers
-
Trump backtracks on plan to toll Hormuz ships
-
Balogun admits red card furore affected US World Cup team
-
France, Spain battle for place in World Cup final
-
Pogacar inspired by Djokovic amid Tour de France jeers
-
Pogacar inspsired by Djokovic amid Tour de France jeers
-
'Gus' the T. rex fetches record $50.1 mn at US auction
-
Croatia ex-international Simic held in graft case
-
Dollar slides as rate hike prospects ease, oil gains moderate
-
Record-smashing US heat wave surges from West to East
-
England won't be drawn into Argentina World Cup rivalry: Kane
-
Why does Brazil's PIX payment system bother Donald Trump?
-
Swiss World Cup squad return home to heroes' welcome
Sacklers, Purdue to pay $7.4 bn over opioid crisis
Several US states have reached a $7.4 billion settlement with the Sackler family and their pharmaceutical company Purdue over the opioid crisis that has ravaged the lives of millions of Americans, officials said Thursday.
The opioid crisis, which has caused more than 500,000 deaths over 20 years in the United States, has triggered a flurry of lawsuits against drugmakers, distributors and pharmacies from victims and the authorities.
Thursday's settlement, which will see funds routed to communities and individuals affected by opioids, is the largest of several targeting the makers and sellers of the highly addictive drugs.
The $7.4 billion settlement was agreed "in principle with members of the Sackler family and their company Purdue Pharma for their instrumental role in creating the opioid crisis," New York Attorney General Letitia James's office said in a statement.
"The settlement ends the Sacklers's control of Purdue and ability to sell opioids in the United States and will deliver funding directly to communities across the country over the next 15 years to support opioid addiction treatment, prevention, and recovery programs.
"The $7.4 billion settlement in principle (is) the nation's largest."
Purdue and other opioid makers and distributors were accused of encouraging free-wheeling prescription of their products through aggressive marketing tactics while hiding how addictive the drugs are.
- Litigation avalanche -
Facing an avalanche of litigation, in 2021 Purdue pled guilty to three criminal charges over its marketing of OxyContin.
The Sacklers have consistently denied wrongdoing over the opioid crisis.
The settlement featured some 15 states including New York, Florida and Pennsylvania.
"The Sackler family relentlessly pursued profit at the expense of vulnerable patients, and played a critical role in starting and fueling the opioid epidemic," James said in a statement.
"While no amount of money will ever fully repair the damage they caused, this massive influx of funds will bring resources to communities in need so that we can heal."
The settlement includes the eight heirs of the original Purdue founders Raymond and Mortimer Sackler who served on the company board -- Richard, Kathe, Mortimer Jr, Ilene, David, and Theresa Sackler.
For many people, opioid addiction begins with prescribed pain pills, before they increase their consumption and eventually turn to illicit drugs such as heroin and fentanyl, an extremely powerful synthetic opioid.
Opioid victims and their families addressed the Sackler family, owners of Purdue Pharma, the maker of OxyContin, directly in a US courtroom in March 2022 as part of the company's bankruptcy case.
"We buried Matthew and Kyle because of your family's vicious acts of disregard for human life," Liz Fitzgerald said of the deaths of two of her sons, who died at ages 32 and 25 after years of dealing with opioid addictions.
"Two boys are gone because of your 'safe' medication," Fitzgerald said.
J.Horn--BTB